You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Dry Eye Syndromes

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 40 total displayed.

Most recent content

Arch Dermatol
Correspondence
The Management of Severe Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Chie Sotozono; Mayumi Ueta; Shigeru Kinoshita
Arch Dermatol 2009; 145: 1336-1337. [Extract] [Full text] [Full text PDF]  

Arch Dermatol
Correspondence
The Management of Severe Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Reply
Julie Gueudry; Michel Binaghi; Marc Muraine
Arch Dermatol 2009; 145: 1337-1338. [Extract] [Full text] [Full text PDF]  

Arch Ophthalmol
Laboratory Sciences
Dry Eye Reversal and Corneal Sensation Restoration With Topical Naltrexone in Diabetes Mellitus
Ian S. Zagon; Matthew S. Klocek; Joseph W. Sassani; Patricia J. McLaughlin
Arch Ophthalmol 2009; 127: 1468-1473. [Abstract] [Full text] [Full text PDF]  

Past content

Arch Ophthalmol
Clinical Sciences
Modalities to Decrease Stromal Herpes Simplex Keratitis Reactivation Rates
John D. Sheppard; Michael L. Wertheimer; Stephen V. Scoper
Arch Ophthalmol 2009; 127: 852-856. [Abstract] [Full text] [Full text PDF]  

Arch Ophthalmol
Laboratory Sciences
Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2
Sunali Goyal; Sunil K. Chauhan; Qiang Zhang; Reza Dana
Arch Ophthalmol 2009; 127: 882-887. [Abstract] [Full text] [Full text PDF]  

Arch Ophthalmol
Epidemiology
Prevalence of Dry Eye Disease Among US Men: Estimates From the Physicians' Health Studies
Debra A. Schaumberg; Reza Dana; Julie E. Buring; David A. Sullivan
Arch Ophthalmol 2009; 127: 763-768. [Abstract] [Full text] [Full text PDF]  

Arch Ophthalmol
Laboratory Sciences
Effect of Chitosan-N-Acetylcysteine Conjugate in a Mouse Model of Botulinum Toxin B–Induced Dry Eye
Teeravee Hongyok; Jemin J. Chae; Young Joo Shin; Daero Na; Li Li; Roy S. Chuck
Arch Ophthalmol 2009; 127: 525-532. [Abstract] [Full text] [Full text PDF]  

Arch Ophthalmol
Clinical Sciences
Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
Melissa M. Brown; Gary C. Brown; Heidi C. Brown; Jonathan Peet; Zachary Roth
Arch Ophthalmol 2009; 127: 146-152. [Abstract] [Full text] [Full text PDF] [ eTables ]  

Arch Dermatol
Studies
Risk Factors for the Development of Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Julie Gueudry; Jean-Claude Roujeau; Michel Binaghi; Gisèle Soubrane; Marc Muraine
Arch Dermatol 2009; 145: 157-162. [Abstract] [Full text] [Full text PDF]  

Arch Ophthalmol
Small Case Series
Sterile Corneal Melt After Descemet Stripping Endothelial Keratoplasty in Patients With Previously Undiagnosed Sjögren Syndrome
Shannon J. C. Shan; Elaine I. Wu; Esen K. Akpek
Arch Ophthalmol 2009; 127: 219-220. [Extract] [Full text] [Full text PDF]  

[Next page]
Pages: 1 2 3 4

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 •Related collections:
  •Ophthalmological Disorders
  •Cataracts/ Lens
  •Choroidal Neovascularization
  •Corneal Disorders
  •Diabetic Retinopathy
  •Dry Eye Syndromes
  •Endophthalmitis
  •External Eye Disease
  •Eye Injuries/ Ocular Trauma
  •Glaucoma
  •Macular Degeneration
  •Macular Disorders
  •Ocular/ Adnexal Tumors
  •Optics/ Refraction
  •Pediatric Ophthalmology
  •Retinal/ Chorioretinal Disorders
  •Retinal Detachment
  •Strabismus
  •Uveitis
  •Vitreous Disorders
  •Ophthalmological Disorders, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.